Roche Court Win Keeps Sandoz' Biosimilar Rituximab Off Australian Market For A Year

 
• By Ian Schofield
  
Australian flag
An Australian court decision has kicked potential rituximab savings down the road

More from Legal & IP

More from Generics Bulletin